Omalizumab is a monoclonal antibody used to treat certain allergic conditions by binding to immunoglobulin E (IgE) and inhibiting allergic responses. It is administered by injection and prescribed for chronic urticaria or severe asthma unresponsive to standard therapies. As a specialized biologic, its use is overseen by a healthcare professional and covered by specific guidelines and insurance policies.
Full pronunciation guide
